Whataboutism and False Equivalency: Why 'Both Sides Are Corrupt' Misses the Point

"But cannabis is becoming just another corporate industry now. What's the difference?" This is one of the most common responses in the alcohol versus cannabis debate — a textbook example of whataboutismthat creates a false equivalency between two fundamentally different historical trajectories. On the surface, pointing out that cannabis is now being commercialised by large corporations seems like a valid counter-argument to criticising alcohol's corporate power. But it entirely ignores the structural journey each substance took to reach this point — and in doing so, obscures one of the most damning stories of political hypocrisy in modern British history.

The Structural Asymmetry

The false equivalency collapses when you examine the historical mechanics of how each substance arrived at its current legal and commercial status. Alcohol's corporate power grew naturally alongside centuries of deep social acceptance. Fermentation was a survival strategy before modern sanitation — beer and wine provided sterile, calorie-dense hydration when water supplies were contaminated. By the time modern governments formed, alcohol was already a massive economic pillar and a primary source of state tax revenue. [Institute of Alcohol Studies]

Cannabis, on the other hand, was aggressively suppressed and criminalised for the masses while the British state quietly handed exclusive, multi-million-pound monopolies to politically connected elites. This is not standard capitalism — it is a masterclass in political hypocrisy.

Alcohol: Legacy Privilege, Not Conspiracy

Alcohol's corruption is about a legacy giant using its historical privilege to dodge health regulations. Powerful trade blocks like the Scotch Whisky Association and the Portman Group have immense access to Westminster. The footprint of this lobbying appears every year during budget announcements, where Chancellors routinely freeze or cut alcohol duties to protect the industry — despite alcohol costing the UK an estimated £27 billion annually in healthcare, policing, and lost productivity. [IPPR, The Cost of Alcohol (2025/2026)]

Alcohol is a multi-billion-pound legal machine that enjoys deep cultural protection, heavily normalised across every social class. Its corrupting influence is quiet, comfortable, and fully legal — the standard behaviour of a legacy industry using its weight to protect its market. It is dirty, but it is standard corporate behaviour.

Cannabis: Prohibition Capitalism

Cannabis's corporate reality is a fundamentally different phenomenon — a product of what can only be described as prohibition capitalism. The state spent decades locking people up for a plant, only to clear the runway for exclusive corporate monopolies to profit from it the moment the political wind changed. The corporate corruption of cannabis did not happen after it became legal; the prohibition itself was used as a tool to ensure that when it did become legal, only the ultra-wealthy and politically connected could own it.

The Ultimate UK Hypocrisy: British Sugar and Victoria Atkins

For years, the UK Home Office maintained a rigid, public stance: cannabis is a dangerous drug with zero therapeutic value. They used this exact argument to arrest ordinary citizens, raid minor operations, and block patients from accessing medicine. Yet, while saying this publicly, the UK government quietly issued a massive, exclusive commercial license to British Sugar to grow acres of high-THC medical cannabis in Norfolk for the pharmaceutical giant GW Pharmaceuticals. [The Independent (2018)]

For a long time, this arrangement helped make the UK one of the largest legal producers and exporters of medical cannabis in the world — all while it remained strictly illegal for its own citizens. The kicker? Victoria Atkins, the Conservative MP who served as the Minister in charge of UK drug policy — and later became Health Secretary — was publicly defending cannabis prohibition while her husband, Paul Kenward, was the Managing Director of British Sugar. The conflict of interest was so glaring that she eventually had to recuse herself from speaking on cannabis policy altogether. [Left Foot Forward (2021)]

Philip May — husband of former Prime Minister Theresa May, whose administration fiercely resisted cannabis reform — worked for Capital Group, a trillion-dollar institutional investment firm. Capital Group happened to be the single largest institutional shareholder in GW Pharmaceuticals, directly profiting from the global expansion of the UK's legal medical cannabis export monopoly while his wife's government maintained strict prohibition on the streets.

The Canadian "Gold Rush" in Parliament

When the UK began moving toward medical legalisation around 2018, it was not driven by a sudden wave of government compassion. It was heavily accelerated by intense corporate lobbying. In 2019, a group called theConservative Drug Policy Reform Group (CDPRG) was launched by MPs like Crispin Blunt to push for drug policy changes. An investigation quickly revealed that this UK "policy group" was bankrolled by roughly £400,000 from giant North American cannabis corporations — including Wayland and Zenabis. These mega-corps were not lobbying for civil liberties or social justice; they saw the UK as an untapped, highly lucrative corporate frontier and were paying UK politicians to help them pry the door open. [OpenDemocracy (2019)]

The Current Reality: The Private Paywall

Even now that medical cannabis is "legal" in the UK — since November 2018 — the suppression has not ended. It has simply shifted into a corporate two-tier system. The NHS almost entirely refuses to prescribe or fund cannabis. Instead, the entire ecosystem has been funnelled into private, venture-capital-backed clinics like Curaleaf, Mamedica, and Sapphire. [Prohibition Partners (2026)]

If you are wealthy enough to pay hundreds of pounds a month for private consultations and corporate-imported flower, your cannabis use is entirely legal. If you are working-class and buying the exact same plant from a local grower because you cannot afford the private clinic fees, you are still treated as a criminal by the state. The National Institute for Health and Care Excellence (NICE) requires large-scale, UK-specific randomised controlled trials before approving widespread NHS funding — trials that remain unfunded and unconducted. Over 1.4 million patients are priced out and forced to turn to the illicit black market.

Why the Whataboutism Misses the Mark

Your partner is looking at the horizon and seeing both industries turning into corporate, profit-driven machines, concluding: "See? It is all the same money-grabbing game." But she is missing the structural journey:

Alcohol was protected by the law to build its empire over centuries. Its corporate power is the product of deep cultural entrenchment, a survival strategy that predates modern regulation.

Cannabis was suppressed by the law to destroy informal economies, only to be legalised in a highly restrictive, corporate-first framework where the NHS barely prescribes it, forcing patients into expensive private clinics. Its corporate capture is the product of a political scam: criminalise the public, then hand the market to insiders.

They are both corporate now. But one was the golden child, protected by law for centuries. The other was a weapon of criminalisation — until it became profitable for the gatekeepers.

For a deeper exploration of the specific corruption cases behind UK cannabis law, read our analysis of UK cannabis laws and political corruption and the War on Drugs as a political weapon.

Sources: [The Independent (2018) — Victoria Atkins Conflict of Interest] | [Left Foot Forward (2021) — UK Cannabis Export Monopoly] | [OpenDemocracy (2019) — CDPRG Corporate Lobbying Investigation] | [IPPR, The Cost of Alcohol (2025/2026)] | [Institute of Alcohol Studies] | [Prohibition Partners (2026)]